According to a research report titled ‘Global Blood Transfusion Diagnostics Market - Analysis By Product (Kits and Reagents, Instruments), Application (Disease Screening, Blood Grouping), End User, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)’, available with Market Study Report, global blood transfusion diagnostics market was valued at USD 2192.55 million in 2020 and is projected to register a healthy growth rate over the forecast period 2021-2026.
 

Report findings state that increased prevalence of chronic diseases is driving the growth of worldwide blood transfusion diagnostics industry. Furthermore, the mounting risk of transfusion-transmitted infections (TTIs) has led to elevated demand for donor screening tests, thereby boosting overall market development.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3733202/
 

Moreover, rising incidences of trauma, and road accidents are also contributing to the industry expansion. The industry will continue evolve with the emergence of new infectious agents and increased recognition of non-infectious hazards of transfusion.
 

Higher risks associated with blood transfusion in select patient populations, such as those suffering from chronic diseases or undergoing cardiac surgery, are further promoting the industry expansion.
 

Elaborating on the recent developments, the Covid-19 pandemic has created new opportunities for global blood transfusion diagnostics market  as extensive plasma transfusion trials are underway in the U.S.
 

Based on application ambit, the market space is arrayed into disease screening and blood grouping. By end-user scope, the industry is split into hospitals, blood banks, and others.
 

Moving on to the product type, global blood transfusion diagnostics market segmentation comprises instruments, and kits & reagents. Rise in number of patients undergoing surgical procedures for chronic diseases has prompted leading companies to focus on research & development activities for assays, advanced instruments, and kits in hospitals and blood banks.
 

From a regional frame of reference, as per the report, global blood transfusion diagnostics market spans across North America (United States, and Canada), Asia Pacific (China, India, Japan, and South Korea), and Europe (France, Germany, U.K., and Italy).
 

Major players in the industry are Biokit S.A., Promega Corp., Quest Diagnostics Inc., Hologic Inc., Danaher Corp., Ortho Clinical Diagnostics Holdings plc, F. Hoffmann-La Roche A.G., Bio-Rad Laboratories Inc. and Abbott Laboratories.